Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055504
Filed
Sep 10, 2021
Trade date
Jul 1-30, 2021
Filing delay
71 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $1.03K. It was filed 71 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2021Common StockPPurchaseAcquired+15$2.91+$43.655,768,529Direct
Jul 2, 2021Common StockPPurchaseAcquired+15$2.94+$44.15,768,544Direct
Jul 6, 2021Common StockPPurchaseAcquired+15$3.14+$47.15,768,559Direct
Jul 7, 2021Common StockPPurchaseAcquired+15$3.21+$48.155,768,574Direct
Jul 8, 2021Common StockPPurchaseAcquired+15$3.18+$47.75,768,589Direct
Jul 9, 2021Common StockPPurchaseAcquired+15$3.13+$46.955,768,604Direct
Jul 12, 2021Common StockPPurchaseAcquired+15$3.33+$49.955,768,619Direct
Jul 13, 2021Common StockPPurchaseAcquired+15$3.48+$52.25,768,634Direct
Jul 14, 2021Common StockPPurchaseAcquired+15$3.33+$49.955,768,649Direct
Jul 15, 2021Common StockPPurchaseAcquired+15$3.27+$49.055,768,664Direct
Jul 16, 2021Common StockPPurchaseAcquired+15$3.28+$49.25,768,679Direct
Jul 19, 2021Common StockPPurchaseAcquired+15$3.23+$48.455,768,694Direct
Jul 20, 2021Common StockPPurchaseAcquired+15$3.24+$48.65,768,709Direct
Jul 21, 2021Common StockPPurchaseAcquired+15$3.26+$48.95,768,724Direct
Jul 22, 2021Common StockPPurchaseAcquired+15$3.36+$50.45,768,739Direct
Jul 23, 2021Common StockPPurchaseAcquired+15$3.35+$50.255,768,754Direct
Jul 26, 2021Common StockPPurchaseAcquired+15$3.41+$51.155,768,769Direct
Jul 27, 2021Common StockPPurchaseAcquired+15$3.39+$50.855,768,784Direct
Jul 28, 2021Common StockPPurchaseAcquired+15$3.42+$51.35,768,799Direct
Jul 29, 2021Common StockPPurchaseAcquired+15$3.42+$51.35,768,814Direct
Jul 30, 2021Common StockPPurchaseAcquired+15$3.31+$49.655,768,829Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)